119 related articles for article (PubMed ID: 2650312)
1. Intravenous cyclosporine for heart transplantation.
Bolman RM; Cance CG
Transplant Proc; 1989 Feb; 21(1 Pt 3):2488. PubMed ID: 2650312
[No Abstract] [Full Text] [Related]
2. Comparison of the safety and efficacy of oral vs constant-rate intravenous infusion cyclosporine immediately following orthotopic heart transplantation.
Myre SA; Schroeder TJ; Melvin DB; Pesce AJ; Collins JA; Stephens GW; First MR
Transplant Proc; 1989 Feb; 21(1 Pt 3):2484-6. PubMed ID: 2650310
[No Abstract] [Full Text] [Related]
3. Intravenous administration of cyclosporine for immunosuppression in heart transplant patients.
Macris MP; Frazier OH; Van Buren CT; Lammermeier DE; Sweeney MS; Kahan BD
Transplant Proc; 1989 Feb; 21(1 Pt 3):2487. PubMed ID: 2650311
[No Abstract] [Full Text] [Related]
4. Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients.
Macris MP; Frazier OH; Van Buren CT; Duncan JM
Transplant Proc; 1988 Jun; 20(3 Suppl 3):311-5. PubMed ID: 3291261
[No Abstract] [Full Text] [Related]
5. Optimization by timing of oral cyclosporine to prevent acute kidney allograft rejection in dogs.
Cavallini M; Halberg F; Sutherland DE; Cornélissen G; Heil J; Najarian JS
Transplantation; 1986 May; 41(5):654-7. PubMed ID: 3518168
[No Abstract] [Full Text] [Related]
6. Influence of different parameters for the monitoring of cyclosporine.
Humbert H; Vernillet L; Cabiac MD; Barradas J; Billaud E
Transplant Proc; 1990 Jun; 22(3):1210-5. PubMed ID: 2349682
[No Abstract] [Full Text] [Related]
7. Long-term effects of cyclosporine in cardiac transplantation.
Miller LW; Pennington DG; McBride LR
Transplant Proc; 1990 Jun; 22(3 Suppl 1):15-20. PubMed ID: 2349734
[No Abstract] [Full Text] [Related]
8. Steady-state concentrations of cyclosporine for therapeutic monitoring.
Grevel J; Napoli KL; Kahan BD
Transplant Proc; 1990 Jun; 22(3):1339-42. PubMed ID: 2190397
[No Abstract] [Full Text] [Related]
9. Kinetics of oral ciclosporin in the perioperative period after heart transplantation.
Konertz W; Leimenstoll G; Weyand M; Friedl A; Bernhard A
Bibl Cardiol; 1988; (43):42-5. PubMed ID: 3067722
[No Abstract] [Full Text] [Related]
10. Comparison of oral and intravenous cyclosporine A in kidney transplants.
Asokan VS; Sweny P; Varghese Z; Moorhead JF; Fernando ON
Transplant Proc; 1987 Feb; 19(1 Pt 2):1717-8. PubMed ID: 3274412
[No Abstract] [Full Text] [Related]
11. Experience with early quadruple immunosuppressive therapy in heart transplantation.
Goenen M; Col J; Baele P; Latinne D; Noel H; Alexandre G; Schoevardts JC; Ponlot R; Chalant C
Bibl Cardiol; 1988; (43):23-6. PubMed ID: 3067718
[No Abstract] [Full Text] [Related]
12. Late cyclosporine conversion carries risk of irreversible rejection.
Sagalowsky AI; Reisman ME; Dawidson I; Toto R; Peters PC; Helderman JH
Transplant Proc; 1988 Jun; 20(3 Suppl 3):157-60. PubMed ID: 3291233
[No Abstract] [Full Text] [Related]
13. Cyclosporine in pediatric liver transplantation: is there a therapeutic blood level that abrogates rejection?
Margarit C; Martinez Ibáñez V; Potau N; Iglesias J; Boix Ochoa J
Transplant Proc; 1988 Jun; 20(3 Suppl 3):369-74. PubMed ID: 3291270
[No Abstract] [Full Text] [Related]
14. Should cyclosporine be continued indefinitely?
Stiller CR; Opelz G
Transplant Proc; 1991 Feb; 23(1 Pt 1):36-40. PubMed ID: 1990552
[No Abstract] [Full Text] [Related]
15. Effects of low-dose cyclosporine A on toxicity and rejection in cardiac transplantation.
Spratt P; Esmore D; Baron D; Shanahan MX; Farnsworth AE; Chang VP
Transplant Proc; 1987 Apr; 19(2):2847-50. PubMed ID: 3551225
[TBL] [Abstract][Full Text] [Related]
16. Induction of unresponsiveness after local low-dose cyclosporine administration.
Stepkowski S; Goto S; Reynolds K; Ito T; Kahan BD
Transplant Proc; 1989 Feb; 21(1 Pt 1):1120-2. PubMed ID: 2650072
[No Abstract] [Full Text] [Related]
17. Cardiac transplantation with low-dose ciclosporin and azathioprine and minimal or no oral steroids.
Konertz W; Weyand M; Friedl A; Semik M; Bernhard A
Bibl Cardiol; 1988; (43):156-8. PubMed ID: 3067716
[No Abstract] [Full Text] [Related]
18. Modulation of accelerated rat cardiac allograft rejection by cyclosporine and ART-18.
DiStefano R; Kupiec-Weglinski JW; Uhteg LC; Puskas J; Araneda D; Diamantstein T; Tilney NL
Transplant Proc; 1988 Apr; 20(2 Suppl 2):217-22. PubMed ID: 3129842
[No Abstract] [Full Text] [Related]
19. [Use of intravenous cyclosporin in the treatment of episodes of irreversible rejection in renal transplantation].
Morales J; Mocarquer A; James E; Aris L; Herrera L; Morales I
Rev Med Chil; 1987 Dec; 115(12):1172-5. PubMed ID: 3332925
[No Abstract] [Full Text] [Related]
20. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
[No Abstract] [Full Text] [Related]
[Next] [New Search]
